Search results
Results from the WOW.Com Content Network
The first line of treatment for hypertension is lifestyle changes, including dietary changes, physical exercise, and weight loss. Although these have all been recommended in scientific advisories, [7] a Cochrane systematic review of available relevant studies found that although weigh-loss diets did reduce body weight and blood pressure, beneficial effects of those changes could not be ...
The patients received 3.3 years of treatment and were followed up with until 2018. ... The findings confirmed that an intensive treatment of hypertension was associated with a significantly lower ...
Low adherence to treatment is an important cause of resistant hypertension. [48] This low adherence to blood pressure treatment is the result of many patients’ generally poor health literacy, costly antihypertensive medications, and inability to accurately follow complex regimens. [49]
A randomized double blind study by the Systolic Hypertension Study in Europe revealed that the incidence of dementia was lowered by 50% in participants that were given pharmacological intervention for hypertension after 2 years and that there was a 55% decrease in the individuals developing Alzheimer's disease and vascular dementia. [29] The ...
They further found diabetes drugs, vitamins and supplements, and antipsychotics were associated with an increased risk, but other classes of treatment including some blood-pressure medications and ...
Taking medications like blood pressure and lipid-lowering drugs for more than 5 years is associated with a lower incidence of dementia, a new study has found.
Treatment of childhood dementia focuses on managing symptoms and improving quality of life. This can include: Medications: Anti-seizure medications, behaviour-modifying drugs, and muscle relaxants. [1] Therapies: Physiotherapy, occupational therapy, and speech therapy are used to maintain physical function for as long as possible. [1]
Comparing diabetes drugs’ effect on dementia risk. To investigate the drug’s links to dementia risk, the researchers compared people with type 2 diabetes taking SGLT-2 inhibitors with those ...